Short answer
SelectQuote, Inc. (SLQT) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $329M (up 12.5% year over year) with net income of −$30M.
Q3 2025 key financials · XBRL
- Revenue
- $329M
- +12.5% YoY
- Net income
- −$30M
- +31.6% YoY
- Operating margin
- -12.4%
- EPS (diluted)
- −$0.26
- +0.0% YoY
Source: XBRL data from the SelectQuote, Inc. (SLQT) Q3 2025 10-Q on SEC EDGAR. USD.
SelectQuote, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $328.8M, up 13% YoY from $292.3M
- Pharmacy revenue $218.5M, up 43%; commissions and services $110.3M, down 21%
- Net loss $30.5M vs $44.5M; operating margin (12%) vs (4%) YoY
- SelectRx members 106,914, up 24%; Life total premiums $48.9M, up 23%
- Interest expense $11.8M, down 49%; $260.0M term-loan repayment using preferred-stock proceeds
Risk Factors
- No material changes to risk factors disclosed in the Annual Report
- Carried-forward business risk from Annual Report remains applicable
- Carried-forward financial-condition risk could materially affect results
- Carried-forward regulatory and compliance risks remain applicable
- No new securities sales during the period covered by Form 10-Q
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SelectQuote, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.